QuValent

QuValent is a quantum mechanics-based computational platform developed by QSimulate, purpose-built for the discovery and optimization of covalent binders. By leveraging quantum mechanical calculations, QuValent addresses a fundamental limitation of classical mechanics approaches: the inability to accurately model covalent bond formation. The platform is designed for computational chemistry and drug discovery teams seeking high-accuracy, automated solutions for covalent drug design.

Because covalent bond formation is inherently a quantum process, no suitable classical mechanics approximation exists. QuValent positions itself as the only computer-aided drug discovery solution capable of rigorously treating this chemistry, enabling computational teams to achieve results that were previously unattainable with conventional tools.

Core Capabilities

• Quantum mechanics engine: Applies quantum mechanical methods to evaluate the effects of covalent bond formation with high accuracy and broad chemical applicability.
• Complete binding mode coverage: Handles all binding scenarios in a single platform, including non-covalent binding, reversible covalent binding, and irreversible covalent binding.
• Warhead tuning: Provides unprecedented computational capabilities for optimizing reactive warhead groups, opening new avenues for medicinal chemistry exploration.
• Automated workflows: Supports automated approaches that streamline quantum mechanical calculations across large compound sets.

Integration and Workflow Compatibility

• Docking score integration: Quantum mechanics evaluations can be incorporated directly into docking and scoring workflows.
• AI/ML workflow compatibility: QuValent can be integrated into artificial intelligence and machine learning pipelines, enabling data-driven covalent drug discovery.
• Broad applicability: Designed to support a wide range of covalent discovery goals, from hit identification through lead optimization.

Key Advantages

• Only solution providing a complete treatment of all covalent binding aspects — non-covalent, reversible covalent, and irreversible covalent — within a single platform.
• Delivers previously untapped computational solutions by applying quantum mechanics where classical force fields are fundamentally inadequate.
• Breaks down barriers for warhead tuning, enabling computational teams to explore chemical space that was inaccessible with prior methods.
• High accuracy powered by quantum mechanics, offering results that go beyond what analytic classical approximations can provide.

QuValent is developed by QSimulate, headquartered in Boston, MA. Supporting resources including whitepapers and webinars are available to help teams evaluate and adopt the platform for their covalent drug discovery programs.